LVV Packaging Test and Manufacturing
Move from vector design to clinical readiness with confidence. ProBio's LVV Packaging Test provides rapid feasibility and manufacturability insights, while our ProLVV Manufacturing Service delivers high-quality lentiviral vectors for non-clinical studies, backed by an end-to-end pathway to IND and GMP manufacturing.
Lentiviral Vector CDMO Services Powered by Advanced Suspension Manufacturing
Risk Reduction
Reduce development risk with early feasibility data. DoE-driven optimization and comprehensive performance testing provide insights needed to make informed decisions and advance promising candidates.
Fast Turnaround Time
Accelerate program decisions with rapid feasibility and manufacturing data. ProBio's LVV Packaging Test delivers insights in as little as 3-5 weeks, enabling a faster transition into Pro Grade FAST manufacturing.
Scaling Confidence
Using consistent cell lines, packaging systems, and scalable suspension and bioreactor platforms, ProBio helps ensure a smoother path from feasibility studies to commercial-ready processes.
Phase Appropriate Support, From Pre-Clinical to Commercial
Adherent and Suspension Cell Lines for Lentiviral Vectors
Suspension Culture System
- Powered by proprietary PowerS™-293T cells
- Scalable suspension manufacturing up to 200L
- Enhanced productivity with up to 4-5× higher yields
- Reduced manufacturing costs by approximately 50%
- High transduction efficiency for improved vector performance and scalability
Adherent Culture System
- Powered by licensed PowerA™-293T cells
- Scalable production capacity up to 50 CF10
- Closed-system manufacturing for improved product quality, stability, and contamination control
Case Study
Consistent High-Titer Lentiviral Vector Production Across Diverse Gene Constructs with ProBio's PowerS™-293T Platform
Resources
FLYER
Viral Vector Packaging for tLVV, LVV, and AAV
Explore IND‑ready manufacturing, combining targeted vector design, robust process development, and streamlined timelines for various viral vectors.
FLYER
Cell Therapy: Plasmid and Lentiviral Vector
Discover an integrated solution from plasmid to LVV, at high quality and speed.
MODALITY HUB
In Vivo CAR-T Modality Hub
Explore all ProBio in vivo CAR-T resources in one convenient location.
WHITE
PAPER
Design of Targeting Lentiviral Vectors and Their Producer Cells for in Vivo CAR-T
Learn about successful LVV design, manufacturing, and downstream application for in vivo CAR-T.
Frequently Asked Questions